Wolverine Trading
CLSD

Wolverine Trading’s Clearside Biomedical CLSD Stock Holding History

Wolverine Trading’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-880
Closed -$15K – 4310
2022
Q4 		$15K Buy
880
+107
+14% +$1.93K ﹤0.01% 3776
2022
Q3 		$13K Buy
+773
New +$16.9K ﹤0.01% 4423
2021
Q3 		– Sell
-1,553
Closed -$111K – 6330
2021
Q2 		$111K Buy
1,553
+600
+63% +$27.9K ﹤0.01% 5352
2021
Q1 		$33K Buy
+953
New +$47.8K ﹤0.01% 5721
2020
Q2 		– Sell
-753
Closed -$20K – 4632
2020
Q1 		$20K Buy
+753
New +$27.8K ﹤0.01% 4425

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wolverine Trading's CLSD Position: Q4 2024 in Review

Wolverine Trading sold out of Clearside Biomedical (CLSD) in Q4 2024, closing a stake of 1,124 shares — an estimated $19.6K sold.

Wolverine Trading first reported a position in CLSD in Q4 2019 and held it in 3 quarters. The position peaked at $76K in Q2 2021. 43 funds tracked by Wall St. Rank hold CLSD as of Q4 2024.

  • Wolverine Trading reported no remaining Clearside Biomedical position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 1,124 Clearside Biomedical shares in Q4 2024, an estimated $19.6K.
  • Wolverine Trading first reported a position in Clearside Biomedical in Q4 2019 and held it in 3 quarters.
  • Wolverine Trading's Clearside Biomedical position peaked at $76K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.